![]() |
| Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Bullion ~ Forex ~ Sports ~ Technology ~ Health ~ Features |
|
Home
/ Technology News / 2008 / January 2008 / January 22, 2008 Melanomas have a different look than other moles |
Stem cell heart surgery may spell the end for transplantation
British scientists have developed a new technique that can rebuild a severely damaged heart, and one day, might replace the need for transplantation. ANI
A new insight into the turbulent atmosphere of Venus
New images taken by instruments on board ESAs (European Space Agencys) Venus Express have provided insight into the turbulent atmosphere of our neighbouring planet. ANI
ESA tests laser to measure atmospheric CO2
A recent ESA (European Space Agency) campaign has demonstrated how a technique using lasers could be employed to measure carbon dioxide (CO2) in the atmosphere. ANI
A recent study revealed that melanomas might appear differently than other irregular skin moles.
Washington, Jan 22: A recent study revealed that melanomas might appear differently than other irregular skin moles.
Melanoma is a critical tumour of melanocytes, cells located in the bottom layer of the skin. It is one of the rare types of skin cancer that causes majority of skin cancer related deaths.
According to the report published in JAMA journal Archives of Dermatology, the rates of malignant melanoma is continuously increasing and early identification helps to treat the disease by removing the tumour.
"The challenge for clinicians who diagnose and treat pigmented skin lesions is to distinguish between malignant melanoma and benign simulants," wrote authors.
Dr Alon Scope of the Memorial Sloan-Kettering Cancer Centre, New York, conducted the study by acquiring the images of the backs of 12 patients.
The patients had at least eight different moles, and five patients had one lesion confirmed as a melanoma.
The experts or participants including eight pigmented lesion experts, 13 general dermatologists, five dermatology nurses and eight non-clinical medical staff, were then asked to evaluate the images and identify lesions that looked different from all other moles.
"The malignant melanomas were apparent as being different to at least 85 percent of participants, whereas the agreement rate on the benign lesions perceived as being different was 76 percent at most," the authors write.
The understanding was 100 percent for the pigmented lesion experts, 89 percent for general dermatologists, 88 percent for nurses and 85 percent for non-clinicians.
ANI